Skip to content

Revvity RVTY Payments of Ordinary Dividends, Common Stock

Payments of Ordinary Dividends, Common Stock at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividendsCommonStock.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's payments of ordinary dividends, common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's payments of ordinary dividends, common stock?
Revvity (RVTY) reported payments of ordinary dividends, common stock of $7.84M in Q1 2026.
How has Revvity's payments of ordinary dividends, common stock changed year-over-year?
Revvity's payments of ordinary dividends, common stock decreased by 7.0% year-over-year, from $8.43M to $7.84M.
What is the long-term trend for Revvity's payments of ordinary dividends, common stock?
Over 4 years (2021 to 2025), Revvity's payments of ordinary dividends, common stock has grown at a 0.3% compound annual growth rate (CAGR), from $32.37M to $32.8M.